CRH Medical Corporation (AMEX:CRHM) is set to announce third quarter earning results on Thursday 12th November 2020, after market close.
Previous Quarter Performance
CRH Medical Corporation unwinded loss for the second quarter of $ 0.04 per share, from the revenue of $ 13.59 million. The consensus estimates are income of $ 0.04 per share from $ 27.81 million in revenue. The bottom line results missed street analysts by $ 0.08 or 200 percent, at the same time, top line results fell short of analysts by $ 14.22 million or 51.13 percent.
Stock Performance
Shares of CRH Medical Corporation traded low $ -0.02 or -0.82 percent on Wednesday, reaching $ 2.42 with volume of 123.40 thousand shares. CRH Medical Corporation has traded high as $ 2.49 and has cracked $ 2.40 on the downward trend
The closing price of $ 2.42, representing a 183.72 % increase from the 52 week low of $ 0.86 and a 44.92 % decrease over the 52 week high of $ 4.43.
The company has a market capital of $ 172.25 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH ORegan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.
